av/prudential-plc--big.svg

COM:PRUDENTIALPLC

Prudential plc

  • Stock

GBP

Last Close

635.00

25/11 09:25

Market Cap

200.15M

Beta: -

Volume Today

264.55K

Avg: -

Company Overview

Metric
Company NamePrudential plcAGON Biotechnology
SymbolPRU
MSH IDCOM:PRUDENTIALPLCCOM:AGONBIOTECHNOLOGY
MarketSTOCKSPRIVATE
SectorFinancial ServicesHealthcare & Health Services
IndustryInsurance - LifeBiotechnology
CountryGBTR
StagePre Seed
Employee Count15.03K
Websiteprudentialplc.comagonbiotechnology.com
LinkedInagon-biyosens%C3%B6r
Founders

Market Metrics

Metric
Market Cap250.76M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue11.97B
Revenue (LTM)
Revenue (NTM)
Gross Profit11.97B
EBITDA1.71B
Operating Income1.71B
Net Income1.70B
EPS0.62
Diluted EPS0.62
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin1
Operating Profit Margin0.34
EBITDA Margin0.14
Net Profit Margin0.18
Return on Equity0.13
Return on Assets0.01
Return on Capital Employed0.02

Valuation Multiples

Metric
P/E Ratio28.10
P/B Ratio1.65
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio3.80
EV Multiple14.22

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover0.12

Cash Flow Metrics

Metric
Operating Cash Flow832M
Free Cash Flow788M
Cash Flow to Debt0.17
Operating Cash Flow/Sales0.08
Free Cash Flow Yield0.04

Balance Sheet Metrics

Metric
Cash & Equivalents1.59B
Accounts Receivable
Inventory
Goodwill896M
Debt to Capitalization0.22
Debt to Assets0.03
Current Ratio0.52
Quick Ratio11.19

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue-0.38